Neurohumoral response and stress hyperglycemia in myocardial infarction

Area of Science:

• Endocrinology
• Cardiology
• Metabolic Syndrome

Background:

• Hyperglycemia increases mortality risk in acute coronary syndromes (ACS).
• Potential causes include glucose metabolism issues or stress response.
• Limited data exists on stress hormones, hyperglycemia, and myocardial infarction outcomes.

Purpose of the Study:

• To investigate the relationship between stress hormones (cortisol, catecholamines), hyperglycemia, and clinical outcomes in patients with myocardial infarction.
• To explore the role of cortisol in stress-induced hyperglycemia during myocardial infarction.

Main Methods:

• Prospective, observational study of patients admitted to a coronary care unit with myocardial infarction.
• Serum glucose, cortisol, and catecholamines measured on admission and 48 hours later.
• Correlation and multivariate analyses performed to assess relationships between variables and outcomes.

Main Results:

• A mild positive correlation found between serum cortisol and glucose levels (p=0.005).
• No significant correlation between glucose and catecholamines.
• Higher serum cortisol and glucose levels were associated with increased risk of heart failure and in-hospital mortality.
• The association between glycemia and mortality was not significant in multivariate analysis, but showed significant interaction with cortisol (p=0.003).

Conclusions:

• Cortisol appears to be a key factor in stress hyperglycemia during myocardial infarction.
• Elevated cortisol may contribute to the adverse cardiovascular effects of hyperglycemia in ACS.
• Further research is needed to confirm these findings and explore therapeutic targets.